Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Sales | 20 | 20 | 20 | 20 | 1,193 |
| Gross Profit | 20 | 20 | 20 | 20 | 1,193 |
| Operating Expenses | 35,879 | 23,700 | 23,562 | 26,516 | -1,981 |
| Operating Income | -35,859 | -23,680 | -23,542 | -26,496 | 3,174 |
| Interest Expense | -8,036 | 3,765 | 9,082 | 28,794 | 6,717 |
| Other Income | -7,776 | -387 | 12,152 | 3,374 | -15,151 |
| Pre-tax Income | -35,599 | -27,832 | -20,472 | -51,916 | -18,694 |
| Net Income Continuous | -35,599 | -27,832 | -20,472 | -51,916 | -18,694 |
| Net Income | $-35,599 | $-27,832 | $-20,472 | $-51,916 | $-18,694 |
| EPS Basic Total Ops | -2,246.55 | -2,999.40 | -2,339.53 | -6,928.61 | -3,209.36 |
| EPS Basic Continuous Ops | -2,250.80 | -2,993.16 | -2,348.13 | -6,920.75 | -3,176.06 |
| EPS Diluted Total Ops | -2,246.55 | -2,999.40 | -2,339.53 | -6,928.61 | -3,209.36 |
| EPS Diluted Continuous Ops | -2,250.80 | -2,993.16 | -2,348.13 | -6,920.75 | -3,176.06 |
| EBITDA(a) | $-34,364 | $-22,113 | $-21,872 | $-24,798 | $5,755 |